Patient-Centered Pathology Reports Improve Prostate Cancer Understanding

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Jan. 3, 2025 -- Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current standard format reports, according to a research letter published online Jan. 2 in the Journal of the American Medical Association.

Cathryn J. Lapedis, M.D., from Michigan Medicine in Ann Arbor, and colleagues compared diagnosis knowledge and worry among adults (aged 55 to 84 years) presented with different formats of prostate biopsy reports. The analysis included 799 participants randomly assigned to the PCPR group, 706 to the standard university report group, and 733 to the standard Veterans Affairs (VA) report group.

The researchers found that 93 percent of participants who received the PCPR accurately identified that the report showed prostate cancer compared with 39 percent of those who received the university report and 56 percent of those who received the VA report. Similarly, more PCPR recipients accurately classified the report as showing either low or high risk (93 percent) compared with 41 percent of university recipients and 36 percent of VA recipients. There was also variance noted by format for accuracy in reporting the total Gleason score (84 percent for the PCPR group versus 48 percent for the university group and 40 percent for the VA group). There was a significant association seen between reported worry and risk level for PCPR recipients, with a higher level of worry in the high-risk scenario and a lower level of worry in the low-risk scenario compared with the other two conditions. The PCPR group reported significantly higher ease of understanding than the standard groups.

"Most study participants could not extract basic information -- including whether they have cancer -- from standard prostate cancer pathology reports but were able to understand this diagnostic information from the PCPRs," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-04 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords